Poseida Therapeutics Inc Ordinary Shares PSTX
News
Poseida Therapeutics to Present New Clinical Data from Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients with Relapsed/Refractory Multiple Myeloma at 21st International Myeloma Society Annual Meeting
Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma
Poseida Therapeutics to Present at Upcoming Investor Conferences
Poseida Rises After Reporting Smaller-Than-Seen Loss, Partnership Progress
Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2024
Poseida Therapeutics Announces Participation in Stifel's 2024 Virtual Cell Therapy Forum
Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences
Poseida Therapeutics Shares Climb on Positive Data for Blood Cancer Treatment